Association between uterine serous carcinoma and breast cancer

This publication has 15 references indexed in Scilit:

• Papillary Serous Carcinoma of the Uterus: Increased Risk of Subsequent or Concurrent Development of Breast Carcinoma
  Gynecologic Oncology, 2001
• A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube
  Gynecologic Oncology, 2001
• BRCA1 germline mutations in women with uterine serous papillary carcinoma
  Obstetrics & Gynecology, 2000
• The endometrial effects of SERMs
  Human Reproduction Update, 2000
• BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
  American Journal of Human Genetics, 2000
• Hormonal Pathology of the Endometrium
  Laboratory Investigation, 2000
• BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum*1
  Obstetrics & Gynecology, 1998
• Tamoxifen Use in Breast Cancer Patients Who Subsequently Develop Corpus Cancer Is Not Associated with a Higher Incidence of Adverse Histologic Features
  Gynecologic Oncology, 1994
• Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
  JNCI Journal of the National Cancer Institute, 1994
• Uterine papillary serous carcinoma
  The American Journal of Surgical Pathology, 1982